Stanford v. Roche, the Bayh-Dole Act, and the Possibility of Unintended Consequences

Article co-written by Yuri Levin-Schwartz, Ph.D., a law clerk at MBHB.

Practices & Technologies

Trade Secrets Counseling Litigation & Appeals Patent Prosecution Trademark, Unfair Competition, Advertising Law & Copyright Biotechnology & Pharmaceuticals Chemical Software & Business Methods Electrical Mechanical & Materials Medical Device & Diagnostics Telecommunications

FTC warns pharma companies it means business with its Orange Book listing policy

AI News Roundup – Export controls on AI models, $3.3 billion AI datacenter, AI-created content labels, and more